Targeted drug tested to keep lung cancer from returning after surgery
NCT ID NCT05546866
Summary
This study is testing whether the drug osimertinib can help prevent lung cancer from coming back after surgery. It is for patients with a specific, less common type of genetic mutation in their cancer. The goal is to see if taking this pill after surgery helps patients stay cancer-free for longer.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NON-SMALL CELL LUNG CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Research Site
Beijing, 100730, China
-
Research Site
Chengdu, 610000, China
-
Research Site
Chengdu, 610041, China
-
Research Site
Fuzhou, 350011, China
-
Research Site
Guangzhou, 510080, China
-
Research Site
Kunming, 650118, China
-
Research Site
Ningbo, 315010, China
-
Research Site
Shijiazhuang, 050051, China
-
Research Site
Suzhou, 215006, China
-
Research Site
Tianjin, 300060, China
Conditions
Explore the condition pages connected to this study.